Back to Search

Closed-loop Treatment for Atrial Fibrillation

Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population

Recruiting Observational Study
Atrial Fibrillation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
Shanghai 10th People's Hospital · Other
Who this trial is looking for

This trial is looking for people with atrial fibrillation to help test a new treatment approach. Participants will receive treatment and follow-up care during the study.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with atrial fibrillation
  • I can understand and sign an informed consent form

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to evaluate the concept of closed-loop treatment of atrial fibrillation for the optimization of the treatment strategy.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * atrial fibrillation patients；Ability to act autonomously, understand and sign informed consent； Exclusion Criteria: * none（All patients with atrial fibrillation were enrolled in this study indiscriminately and followed up）
Contacts

DongDong Zhao, PhD

+86 18917684008

zhaodd@tongji.edu.cn

CONTACT

Jun Zhang, MD

+86 15000420881

zhangjun_njmu2011@163.com

CONTACT

NCT ID: NCT05311137 Source: ClinicalTrials.gov